| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | n/a | n/a |
| Intrinsic value (DCF) | n/a | |
| Graham-Dodd Method | 6.73 | 50 |
| Graham Formula | 104.63 | 2225 |
Apollo Healthcare Corp. (AHC.TO) is a Canadian private equity firm specializing in buyouts, with a focus on founder-led businesses, carve-outs of non-core assets, industry consolidation, and growth-oriented opportunities. Headquartered in Toronto, the firm primarily invests in private label consumer staples and aviation finance and asset management sectors, typically seeking majority stakes in its portfolio companies. Operating in the Household & Personal Products industry under the Consumer Defensive sector, Apollo Healthcare Corp. leverages its strategic expertise to drive value creation in stable, recession-resistant markets. With a disciplined investment approach, the firm targets businesses with strong cash flow potential and scalability. Despite its relatively recent founding in 2015, Apollo Healthcare Corp. has demonstrated financial resilience, reporting robust revenue and net income figures in its fiscal year ending December 31, 2020. The company's focus on essential consumer goods positions it well for long-term growth amid economic fluctuations.
Apollo Healthcare Corp. presents a compelling investment case due to its focus on recession-resistant consumer staples and aviation finance sectors, which offer stable cash flows. The firm’s FY2020 financials reflect strong performance, with revenue of CAD 321.7 million and net income of CAD 79.9 million, translating to a diluted EPS of CAD 1.08. Operating cash flow was healthy at CAD 108.7 million, and the company maintains a conservative debt profile with total debt of CAD 15.3 million. However, investors should note the absence of dividends and the firm’s beta of 1.52, indicating higher volatility relative to the market. The private equity model carries inherent risks, including dependence on successful exits and economic cycles, but Apollo’s focus on essential industries mitigates some downside risks. The lack of a market cap figure suggests potential liquidity concerns, warranting further due diligence.
Apollo Healthcare Corp. competes in a niche segment of private equity, focusing on consumer defensive and aviation finance sectors. Its competitive advantage lies in its targeted investment strategy, emphasizing founder-led businesses and non-core carve-outs, which often present undervalued opportunities. The firm’s preference for majority stakes allows for greater control over operational improvements and value creation. However, its relatively small scale compared to global private equity giants may limit access to larger deals. The consumer staples focus provides stability, but the firm’s high beta suggests sensitivity to market swings, possibly due to its concentrated portfolio. Apollo’s ability to identify and integrate acquisitions efficiently will be critical to maintaining its edge. The firm’s financial health, with strong operating cash flow and manageable debt, supports its growth ambitions, but it must contend with larger players with deeper pockets and broader geographic reach.